IRIS
ESPOSITO, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.981
NA - Nord America 15.478
AS - Asia 11.091
SA - Sud America 3.458
AF - Africa 308
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 49.352
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.050
RU - Federazione Russa 10.138
SG - Singapore 4.905
CN - Cina 2.988
BR - Brasile 2.947
IE - Irlanda 2.199
SE - Svezia 1.814
IT - Italia 1.480
HK - Hong Kong 1.153
DE - Germania 683
VN - Vietnam 615
FR - Francia 499
GB - Regno Unito 438
PL - Polonia 420
UA - Ucraina 418
FI - Finlandia 348
IN - India 325
CA - Canada 219
AR - Argentina 180
MX - Messico 147
TR - Turchia 136
BD - Bangladesh 134
NL - Olanda 123
AT - Austria 113
ZA - Sudafrica 102
ID - Indonesia 99
JP - Giappone 99
IQ - Iraq 95
EC - Ecuador 86
BE - Belgio 84
PK - Pakistan 81
UZ - Uzbekistan 72
MA - Marocco 66
VE - Venezuela 66
ES - Italia 60
CO - Colombia 59
CL - Cile 37
IR - Iran 35
AE - Emirati Arabi Uniti 33
JO - Giordania 32
PY - Paraguay 31
SA - Arabia Saudita 30
TN - Tunisia 28
MY - Malesia 27
CZ - Repubblica Ceca 25
LT - Lituania 25
PH - Filippine 24
KE - Kenya 21
PE - Perù 21
AZ - Azerbaigian 20
DZ - Algeria 20
AU - Australia 19
KG - Kirghizistan 19
EG - Egitto 18
IL - Israele 18
NP - Nepal 18
OM - Oman 17
UY - Uruguay 17
PS - Palestinian Territory 16
TH - Thailandia 14
DO - Repubblica Dominicana 13
TW - Taiwan 13
BO - Bolivia 12
HU - Ungheria 12
PA - Panama 12
CI - Costa d'Avorio 11
CH - Svizzera 10
KR - Corea 10
KZ - Kazakistan 10
LB - Libano 10
NO - Norvegia 9
AL - Albania 8
AO - Angola 8
GE - Georgia 8
HN - Honduras 8
RS - Serbia 8
BG - Bulgaria 7
BY - Bielorussia 7
EE - Estonia 7
JM - Giamaica 7
CR - Costa Rica 6
PT - Portogallo 6
RO - Romania 6
DK - Danimarca 5
ET - Etiopia 5
EU - Europa 5
GR - Grecia 5
LA - Repubblica Popolare Democratica del Laos 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
CG - Congo 4
GT - Guatemala 4
LK - Sri Lanka 4
LV - Lettonia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
BA - Bosnia-Erzegovina 3
Totale 49.290
Salva come PNG Salva come JPEG
Città #
Moscow 2.967
Ashburn 2.733
Singapore 2.442
Dublin 2.198
Dallas 1.646
Chandler 1.614
Nyköping 1.215
Hong Kong 1.144
Beijing 916
Jacksonville 826
San Jose 558
The Dalles 528
Messina 435
Princeton 404
Warsaw 398
Los Angeles 377
Dearborn 348
Lauterbourg 333
Medford 312
New York 291
Des Moines 264
Boardman 260
Cambridge 251
Munich 237
São Paulo 236
Ann Arbor 232
Ho Chi Minh City 183
Buffalo 182
Tianjin 152
Guangzhou 133
Lancaster 128
Hanoi 126
Redondo Beach 121
Rio de Janeiro 105
Orem 102
Shenyang 101
Jinan 100
Houston 97
Tokyo 89
Rome 88
Wilmington 88
Santa Clara 82
Brussels 81
Vienna 79
Catania 74
Frankfurt am Main 73
Nanjing 73
Montreal 72
Belo Horizonte 67
Milan 67
Chennai 65
Pune 64
San Mateo 64
Tashkent 62
Council Bluffs 61
Woodbridge 61
Ottawa 59
Brooklyn 56
Shanghai 56
Cologne 53
London 53
Turku 53
Johannesburg 52
Hyderabad 50
Shenzhen 50
Atlanta 49
Chicago 48
Dong Ket 48
Hebei 48
Mexico City 48
Baghdad 47
Jakarta 47
Zhengzhou 47
Ningbo 46
Curitiba 44
Denver 44
Amsterdam 43
San Francisco 43
Haikou 42
Stockholm 42
Brasília 40
Düsseldorf 39
Palermo 37
Seattle 37
Campinas 36
Boston 35
Guayaquil 35
Poplar 35
Helsinki 34
Manchester 34
Phoenix 34
Porto Alegre 34
Nanchang 33
Nuremberg 33
Salvador 33
Istanbul 32
Ankara 30
Falls Church 30
Taizhou 30
Buenos Aires 29
Totale 27.853
Salva come PNG Salva come JPEG
Nome #
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. 253
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 246
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. 243
Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein 237
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 228
PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury 226
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 225
A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss 222
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 218
Celenterati Cnidari come modello per lo studio di tossicità da metalli pesanti. 215
3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease 213
Absence of endogenous Interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. 212
Influence of coagulase-negative staphylococci as potential probiotics on Dry Eye 212
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 206
Effects of Physical Exercise and Motor Activity on Oxidative Stress and Inflammation in Post Mastectomy Pain Syndrome 203
Dimethyl fumarate reduces inflammatory responses in experimental colitis 203
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 203
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 202
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 198
Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-alpha 197
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 197
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies 196
Beneficial effect of tempol, a membrane-permeable radical scavenger, on inflammation and osteoarthritis in in vitro models 196
Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. 195
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 193
Correction to: Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: Enhanced drug solubility, stability, and anti-inflammatory effect (Molecular Pharmaceutics (2017) 14:5 (1610-1622) DOI: 10.1021/acs.molpharmaceut.6b01066) 191
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 189
Protein Hydrolysates from Anchovy (Engraulis encrasicolus) Waste: In Vitro and In Vivo Biological Activities 189
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 188
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 187
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 187
Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. 184
Antioxidant and anti-inflammatory effect of nrf2 inducer dimethyl fumarate in neurodegenerative diseases 183
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy 182
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury 181
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 181
A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock 180
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 179
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 178
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 177
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 176
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 175
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 173
Adenosine A2A receptor selective stimulation reduces mitogen activated protein kinases in spinal cord injury: activation of jnk is reduced in oligodendrocytes 173
Carbon dots as promising tools for cancer diagnosis and therapy 171
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 170
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 169
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 169
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 169
A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury. 169
Absence of peroxisome proliferators activated receptors alpha (PPAR-) enhanced the multiple organ failure induced by zymosan. 168
Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice 165
Aspetti tossicologici di estratto crudo da Pelagia noctiluca (Cnidaria: Scyphozoa). 164
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 163
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 162
Role of melatonin supplementation in neurodegenerative disorders. 162
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents 162
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 161
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 161
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 161
Adenosine A2a receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma (Biological Regulators and Homeostatical Agents (73)) 160
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-alpha MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE. 159
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 159
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury 158
Effects of Physical Exercise and Motor Activity on Depression and Anxiety in Post-Mastectomy Pain Syndrome 157
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 156
Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors 155
Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury 154
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 153
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 152
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 152
Effect of co-ultramicronized palmitoylethanolamide and luteolin association on neurogenesis in a mouse model of spinal cord injury 152
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance 151
BENEFICIAL EFFECTS OF ETHYL PYRUVATE IN A MOUSE MODEL OF SPINAL CORD INJURY. 150
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 150
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 150
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. 149
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 149
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 148
Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 148
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 148
Au, Pd and maghemite nanofunctionalized hydroxyapatite scaffolds for bone regeneration 148
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness 147
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. 146
Autophagy and Liver Diseases 146
A controlled cortical impact preclinical model of traumatic brain injury 144
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma 144
Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis. 143
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice 143
Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury 143
P12.05 Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 141
Inhibition of Poly(ADP-Ribose) Polymerase Activity Modulates Autophagy Induced by Experimental Spinal Cord Trauma 140
Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury 139
GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON SEPTICK SHOCK IN MICE 139
Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis 138
Deficiencies in Toll like receptors 4 impair the functional recovery in a mouse model of spinal cord trauma 138
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis 137
Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept 136
Palmitoylethanolamide ameliorates development of colitis caused by injection of dinitrobenzene sulfonic acid (DNBS) in mice 136
Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease 135
Totale 17.331
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021444 0 0 0 0 0 0 0 0 0 227 93 124
2021/20222.328 23 173 55 92 117 36 181 91 75 132 470 883
2022/20236.430 533 524 288 528 465 644 95 356 2.705 46 178 68
2023/20241.837 128 271 108 156 157 404 82 101 23 99 35 273
2024/20258.678 164 89 259 405 410 248 278 1.590 2.144 505 1.047 1.539
2025/202625.170 1.344 1.595 2.023 1.965 2.132 5.448 3.171 3.074 3.241 1.177 0 0
Totale 50.217